Pseudomonas Infections: all 136 studies
Page 1 of 2. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas AeruginosaNot yet recruitingNCT07804082Phase 3
- Microbiological Screening Of Malignant Otitis Externa Patients Presenting at Sohag University HospitalsRecruitingNCT07790679
- First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected PatientsRecruitingNCT07708116Phase 1
- Ceftazidime-Avibactam PK/PD and Resistance in Hematology PatientsNot yet recruitingNCT07703644
- MP101 in Adults With Acute Pseudomonas Aeruginosa PneumoniaRecruitingNCT07492771Phase 1
- Early Optimization of Ceftazidime Regimen in Critical CareNot yet recruitingNCT07085624Not applicable
- Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas AeruginosaRecruitingNCT07056881
- Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Imaging Technology and Assessment of Post-treatment Efficacy in Patients With Pseudomonas Aeruginosa InfectionNot yet recruitingNCT06986512
- Remote Sputum Collection in Cystic FibrosisRecruitingNCT06950892
- Pathobiomes in Gut of Critically Ill PatientsRecruitingNCT06822465
- CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill PatientsRecruitingNCT06811727Phase 4
- Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)RecruitingNCT06760273
- Antimicrobial Therapy for Difficult-to-treat Pseudomonas AeruginosaRecruitingNCT06738771
- Phenotypic and Genotypic Characteristics of Pseudomonas Aeruginosa Isolates in Sohag University HospitalsRecruitingNCT06417593
- Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the PatientNot yet recruitingNCT06370299
- Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®RecruitingNCT06319235Phase 1/2
- Impact of Modifications to the Rendering of the Antibiogram on the Prescriptions of Meropenem in Pseudomonas BacteremiaRecruitingNCT06113107
- Gram-Negative Bloodstream Infection Oral Antibiotic Therapy TrialRecruitingNCT06080698Not applicable
- Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and BronchiectasisNot yet recruitingNCT06035055Phase 4
- Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder CancerRecruitingNCT05975151Phase 2
- Clinical Outcomes in Patients With Infection by Resistant MicroorganismEnrolling by invitationNCT05880069
- Further MT for Antibiotic-Resistant Bacterial ColonizationRecruitingNCT05835206Phase 2
- Research on the Mechanism Affecting Progression of BronchiectasisRecruitingNCT05731427
- Trikafta/Kaftrio and Pseudomonas AeruginosaRecruitingNCT05675592
- Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas AeruginosaRecruitingNCT05642767
- Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas AntibodiesRecruitingNCT04335383
- Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa SepsisRecruitingNCT03044223
- Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa InfectionCompletedNCT05616221Phase 2Results posted
- A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas AeruginosaCompletedNCT05453578Phase 1/2Results posted
- CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)CompletedNCT04684641Phase 1/2Results posted
- Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell TransplantationTerminatedNCT04673175Phase 4Results posted
- Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic FibrosisCompletedNCT04596319Phase 1/2Results posted
- The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and PseudomonasTerminatedNCT03158116Phase 4Results posted
- Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa PneumoniaCompletedNCT03027609Phase 2Results posted
- Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated SubjectsCompletedNCT02696902Phase 2Results posted
- Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis PatientsCompletedNCT02421120Phase 4Results posted
- A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)CompletedNCT02354859Phase 2Results posted
- Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.AeruginosaTerminatedNCT02248922Phase 4Results posted
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic FibrosisCompletedNCT02054156Phase 3Results posted
- Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)CompletedNCT01844778Phase 4Results posted
- Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic FibrosisTerminatedNCT01694069Phase 4Results posted
- Clinical Trials to Reduce the Risk of Antimicrobial ResistanceTerminatedNCT01570192Phase 2Results posted
- Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) ChildrenCompletedNCT01429259Phase 4Results posted
- Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower AirwaysCompletedNCT01404234Phase 3Results posted
- Aztreonam Lysine for Pseudomonas Infection Eradication StudyCompletedNCT01375049Phase 2Results posted
- Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa InfectionsCompletedNCT01315678Phase 3Results posted
- Second Open Label Extension to Bridging Study CTBM100C2303CompletedNCT01069705Phase 3Results posted
- Open Label Extension to Bridging Study CTBM100C2303CompletedNCT00982930Phase 3Results posted
- Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.CompletedNCT00775138Phase 2Results posted
- Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas AeruginosaCompletedNCT00757237Phase 3Results posted
- Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. AeruginosaCompletedNCT00712166Phase 3Results posted
- Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas AeruginosaCompletedNCT00638365Phase 1/2Results posted
- A Study of Ceftobiprole in Patients With Fever and Neutropenia.TerminatedNCT00529282Phase 3Results posted
- Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)CompletedNCT00128492Phase 3Results posted
- International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedNCT00112359Phase 3Results posted
- Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedNCT00104520Phase 3Results posted
- Development and Validation of (Bio)Sensors for the Identification of PathogensCompletedNCT06548841
- Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)CompletedNCT06141837
- Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in BronchiectasisCompletedNCT06093191Phase 4
- A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung InfectionCompletedNCT06016088Phase 1/2
- PMT for MDRO DecolonizationCompletedNCT05632315Phase 2
- Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.CompletedNCT05282082
- Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa BacteraemiaActive, not recruitingNCT05210439Phase 4
- Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli InfectionsTerminatedNCT05210387Not applicable
- Cystic Fibrosis Blood NeutrophilsCompletedNCT04970225Not applicable
- Phage Therapy for the Prevention and Treatment of Pressure Ulcers.Status unknownNCT04815798Phase 1/2
- Bacteriophage Therapy TP-102 in Diabetic Foot UlcersCompletedNCT04803708Phase 1/2
- Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary DiseaseStatus unknownNCT04803695
- Effect of Metallic Nanoparticles on Nosocomial BacteriaStatus unknownNCT04775238Not applicable
- Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/SepticemiaNo longer availableNCT04636554
- Phage Therapy for the Prevention and Treatment of Wound Infections in Burned PatientsStatus unknownNCT04323475Phase 1
- Animal-Assisted Visitation Program Chlorhexidine TrialCompletedNCT04171817Phase 4
- Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.Status unknownNCT03910920
- Tobramycin in Bronchiectasis Colonized With Pseudmonas AeruginosaStatus unknownNCT03715322Phase 3
- SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis SubjectsStatus unknownNCT03669614Phase 1/2
- Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaCompletedNCT03638830Phase 2
- Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumoniaCompletedNCT03581370Phase 3
- Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas InfectionsCompletedNCT03510351
- Pentaglobin in CRE and PA Neutropenic InfectionsActive, not recruitingNCT03494959Phase 2
- Targeted AntiBiotics for Chronic Pulmonary DiseasesTerminatedNCT03262142Phase 4
- Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant PathogensStatus unknownNCT03159078Phase 3
- FMT for MDRO Colonization After Infection in Renal Transplant RecipientsTerminatedNCT02922816Phase 1
- Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic FibrosisCompletedNCT02894684Phase 4
- Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)CompletedNCT02634411Not applicable
- RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot StudyCompletedNCT02295566Phase 2
- Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy SubjectsCompletedNCT02178254Phase 1
- Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)CompletedNCT02104245Phase 3
- Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa InfectionStatus unknownNCT02102152Not applicable
- Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa PneumoniaCompletedNCT02096328Phase 2
- Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.TerminatedNCT02096315Phase 2
- Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch HospitalsCompletedNCT02007343
- Pseudomonal Type Three Secretion System and Contact Lens Associated Microbial KeratitisStatus unknownNCT01925846
- Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)CompletedNCT01919762
- Bacteriophage Effects on Pseudomonas AeruginosaCompletedNCT01818206Not applicable
- Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN)CompletedNCT01745796
- Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic TreatmentCompletedNCT01695343Phase 2
- Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000CompletedNCT01651455
- The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic FibrosisCompletedNCT01616862
- Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas AeruginosaCompletedNCT01577368Phase 3
- Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43CompletedNCT01563263Phase 2/3